Efficacy Of Rivaroxaban Versus Warfarin For The Treatment Of Deep Vein Thrombosis At Tertiary Care Hospital, Islamabad Article Swipe

PDF

Mahnoor Yousaf , Aneza Jalil , Maria Zafar , Zunaira Sajjad , Morshed Nasir ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.37939/jrmc.v29i3.2901

Objective: The occurrence of venous thromboembolism outside the pulmonary arteries or lower extremity conventional deep vein is referred to as deep vein thrombosis (DVT). The optimal anticoagulation treatment for deep vein thrombosis remained debatable. Therefore, the purpose of the current study was to compare Rivaroxaban versus Warfarin in treating deep vein thromboembolism at the Tertiary Care Hospital, Islamabad. Methods: A randomised controlled trial investigated 170 deep vein thrombosis (DVT) patients in the Department of Medicine, Pakistan Institute of Medical Sciences, Islamabad, from July 2023 to January 2024. Patients were categorised into two groups: Group R (Rivaroxaban) (N=85) and Group W (Warfarin) (N=85). Demographic data, such as age, gender, comorbidities, clinical outcomes, and efficacy recorded for both groups. Major bleeding included any fatal bleeding, bleeding in critical organs, or bleeding causing a haemoglobin drop ≥2 g/dL or requiring ≥2 units of blood transfusion. Minor bleeding is defined as overt bleeding, including events like mild epistaxis or bruising not requiring medical intervention. SPSS version 16 was used for statistical analysis. Results: The overall mean age of group R and W was 47.78±17.91 years and 46.45±18.01 years, respectively. Out of 170 patients, there were 83 (48.8%) males and 87 (51.2%) females. Gender based distribution of patients in both groups was as follows: Group R, N=85 (Male 42 (49.4%) and female 43 (50.6%) and Group W (Male 41 (48.2%) and female 44 (51.8%). Rivaroxaban (Group-R) showed higher efficacy, 72 (84.7%), than Warfarin (Group-W), 62 (72.9%). Conclusion: The present study observed that treatment with Rivaroxaban is preferred over Warfarin due to reduced risk of DVT, major bleeding, and minor bleeding.

Related Topics

Concepts

No concepts available.

Metadata

Type: article
Landing Page: https://doi.org/10.37939/jrmc.v29i3.2901
PDF: https://journalrmc.com/index.php/JRMC/article/download/2901/2698
OA Status: gold
References: 28
OpenAlex ID: https://openalex.org/W4415654060

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4415654060

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.37939/jrmc.v29i3.2901

Digital Object Identifier
Title: Efficacy Of Rivaroxaban Versus Warfarin For The Treatment Of Deep Vein Thrombosis At Tertiary Care Hospital, Islamabad

Work title
Type: article

OpenAlex work type
Publication year: 2025

Year of publication
Publication date: 2025-09-29

Full publication date if available
Authors: Mahnoor Yousaf, Aneza Jalil, Maria Zafar, Zunaira Sajjad, Morshed Nasir

List of authors in order
Landing page: https://doi.org/10.37939/jrmc.v29i3.2901

Publisher landing page
PDF URL: https://journalrmc.com/index.php/JRMC/article/download/2901/2698

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://journalrmc.com/index.php/JRMC/article/download/2901/2698

Direct OA link when available
Cited by: 0

Total citation count in OpenAlex
References (count): 28

Number of works referenced by this work

Full payload

id	https://openalex.org/W4415654060
doi	https://doi.org/10.37939/jrmc.v29i3.2901
ids.doi	https://doi.org/10.37939/jrmc.v29i3.2901
ids.openalex	https://openalex.org/W4415654060
fwci
type	article
title	Efficacy Of Rivaroxaban Versus Warfarin For The Treatment Of Deep Vein Thrombosis At Tertiary Care Hospital, Islamabad
biblio.issue	3
biblio.volume	29
biblio.last_page
biblio.first_page
is_xpac	False
apc_list.value	35
apc_list.currency	USD
apc_list.value_usd	35
apc_paid.value	35
apc_paid.currency	USD
apc_paid.value_usd	35
language
locations[0].id	doi:10.37939/jrmc.v29i3.2901
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S4210189281
locations[0].source.issn	1683-3562, 1683-3570
locations[0].source.type	journal
locations[0].source.is_oa	True
locations[0].source.issn_l	1683-3562
locations[0].source.is_core	False
locations[0].source.is_in_doaj	True
locations[0].source.display_name	Journal of Rawalpindi Medical College
locations[0].source.host_organization
locations[0].source.host_organization_name
locations[0].license	cc-by-sa
locations[0].pdf_url	https://journalrmc.com/index.php/JRMC/article/download/2901/2698
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-sa
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Journal of Rawalpindi Medical College
locations[0].landing_page_url	https://doi.org/10.37939/jrmc.v29i3.2901
indexed_in	crossref, doaj
authorships[0].author.id	https://openalex.org/A5120171541
authorships[0].author.orcid
authorships[0].author.display_name	Mahnoor Yousaf
authorships[0].author_position	first
authorships[0].raw_author_name	Mahnoor Yousaf
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5076034418
authorships[1].author.orcid
authorships[1].author.display_name	Aneza Jalil
authorships[1].author_position	middle
authorships[1].raw_author_name	Aneza Jalil
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5008010307
authorships[2].author.orcid	https://orcid.org/0000-0002-3035-4550
authorships[2].author.display_name	Maria Zafar
authorships[2].author_position	middle
authorships[2].raw_author_name	Maria Zafar
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5120171542
authorships[3].author.orcid
authorships[3].author.display_name	Zunaira Sajjad
authorships[3].author_position	middle
authorships[3].raw_author_name	Zunaira Sajjad
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5010150920
authorships[4].author.orcid	https://orcid.org/0000-0001-5296-7406
authorships[4].author.display_name	Morshed Nasir
authorships[4].author_position	last
authorships[4].raw_author_name	Maham Nasir
authorships[4].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://journalrmc.com/index.php/JRMC/article/download/2901/2698
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-29T00:00:00
display_name	Efficacy Of Rivaroxaban Versus Warfarin For The Treatment Of Deep Vein Thrombosis At Tertiary Care Hospital, Islamabad
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.37939/jrmc.v29i3.2901
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4210189281
best_oa_location.source.issn	1683-3562, 1683-3570
best_oa_location.source.type	journal
best_oa_location.source.is_oa	True
best_oa_location.source.issn_l	1683-3562
best_oa_location.source.is_core	False
best_oa_location.source.is_in_doaj	True
best_oa_location.source.display_name	Journal of Rawalpindi Medical College
best_oa_location.source.host_organization
best_oa_location.source.host_organization_name
best_oa_location.license	cc-by-sa
best_oa_location.pdf_url	https://journalrmc.com/index.php/JRMC/article/download/2901/2698
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-sa
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Journal of Rawalpindi Medical College
best_oa_location.landing_page_url	https://doi.org/10.37939/jrmc.v29i3.2901
primary_location.id	doi:10.37939/jrmc.v29i3.2901
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S4210189281
primary_location.source.issn	1683-3562, 1683-3570
primary_location.source.type	journal
primary_location.source.is_oa	True
primary_location.source.issn_l	1683-3562
primary_location.source.is_core	False
primary_location.source.is_in_doaj	True
primary_location.source.display_name	Journal of Rawalpindi Medical College
primary_location.source.host_organization
primary_location.source.host_organization_name
primary_location.license	cc-by-sa
primary_location.pdf_url	https://journalrmc.com/index.php/JRMC/article/download/2901/2698
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-sa
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Journal of Rawalpindi Medical College
primary_location.landing_page_url	https://doi.org/10.37939/jrmc.v29i3.2901
publication_date	2025-09-29
publication_year	2025
referenced_works	https://openalex.org/W3015957128, https://openalex.org/W3011572213, https://openalex.org/W3002146506, https://openalex.org/W3139350161, https://openalex.org/W4411746866, https://openalex.org/W3129407342, https://openalex.org/W4225373605, https://openalex.org/W3037169514, https://openalex.org/W3036543389, https://openalex.org/W3178350248, https://openalex.org/W2986934488, https://openalex.org/W3113407470, https://openalex.org/W4399594998, https://openalex.org/W3133271016, https://openalex.org/W3005220004, https://openalex.org/W3096748079, https://openalex.org/W3016703611, https://openalex.org/W4394960737, https://openalex.org/W3081392191, https://openalex.org/W3213926992, https://openalex.org/W4316467934, https://openalex.org/W4292553907, https://openalex.org/W4221020965, https://openalex.org/W4293773289, https://openalex.org/W3020538686, https://openalex.org/W4404696092, https://openalex.org/W4391538475, https://openalex.org/W4402308931
referenced_works_count	28
abstract_inverted_index.A	59
abstract_inverted_index.R	94, 175
abstract_inverted_index.W	99, 177, 221
abstract_inverted_index.a	130
abstract_inverted_index.16	162
abstract_inverted_index.41	223
abstract_inverted_index.42	213
abstract_inverted_index.43	217
abstract_inverted_index.44	227
abstract_inverted_index.62	239
abstract_inverted_index.72	234
abstract_inverted_index.83	191
abstract_inverted_index.87	195
abstract_inverted_index.R,	210
abstract_inverted_index.as	19, 105, 146, 207
abstract_inverted_index.at	52
abstract_inverted_index.in	47, 70, 124, 203
abstract_inverted_index.is	16, 144, 250
abstract_inverted_index.of	3, 37, 73, 77, 139, 173, 186, 201, 258
abstract_inverted_index.or	10, 127, 135, 154
abstract_inverted_index.to	18, 42, 84, 255
abstract_inverted_index.170	64, 187
abstract_inverted_index.Out	185
abstract_inverted_index.The	1, 24, 169, 242
abstract_inverted_index.age	172
abstract_inverted_index.and	97, 111, 176, 181, 194, 215, 219, 225, 262
abstract_inverted_index.any	120
abstract_inverted_index.due	254
abstract_inverted_index.for	28, 114, 165
abstract_inverted_index.not	156
abstract_inverted_index.the	7, 35, 38, 53, 71
abstract_inverted_index.two	91
abstract_inverted_index.was	41, 163, 178, 206
abstract_inverted_index.2023	83
abstract_inverted_index.Care	55
abstract_inverted_index.DVT,	259
abstract_inverted_index.July	82
abstract_inverted_index.N=85	211
abstract_inverted_index.SPSS	160
abstract_inverted_index.age,	106
abstract_inverted_index.both	115, 204
abstract_inverted_index.deep	14, 20, 29, 49, 65
abstract_inverted_index.drop	132
abstract_inverted_index.from	81
abstract_inverted_index.g/dL	134
abstract_inverted_index.into	90
abstract_inverted_index.like	151
abstract_inverted_index.mean	171
abstract_inverted_index.mild	152
abstract_inverted_index.over	252
abstract_inverted_index.risk	257
abstract_inverted_index.such	104
abstract_inverted_index.than	236
abstract_inverted_index.that	246
abstract_inverted_index.used	164
abstract_inverted_index.vein	15, 21, 30, 50, 66
abstract_inverted_index.were	88, 190
abstract_inverted_index.with	248
abstract_inverted_index.≥2	133, 137
abstract_inverted_index.(DVT)	68
abstract_inverted_index.(Male	212, 222
abstract_inverted_index.2024.	86
abstract_inverted_index.Group	93, 98, 209, 220
abstract_inverted_index.Major	117
abstract_inverted_index.Minor	142
abstract_inverted_index.based	199
abstract_inverted_index.blood	140
abstract_inverted_index.data,	103
abstract_inverted_index.fatal	121
abstract_inverted_index.group	174
abstract_inverted_index.lower	11
abstract_inverted_index.major	260
abstract_inverted_index.males	193
abstract_inverted_index.minor	263
abstract_inverted_index.overt	147
abstract_inverted_index.study	40, 244
abstract_inverted_index.there	189
abstract_inverted_index.trial	62
abstract_inverted_index.units	138
abstract_inverted_index.years	180
abstract_inverted_index.(DVT).	23
abstract_inverted_index.(N=85)	96
abstract_inverted_index.Gender	198
abstract_inverted_index.events	150
abstract_inverted_index.female	216, 226
abstract_inverted_index.groups	205
abstract_inverted_index.higher	232
abstract_inverted_index.showed	231
abstract_inverted_index.venous	4
abstract_inverted_index.versus	45
abstract_inverted_index.years,	183
abstract_inverted_index.(48.2%)	224
abstract_inverted_index.(48.8%)	192
abstract_inverted_index.(49.4%)	214
abstract_inverted_index.(50.6%)	218
abstract_inverted_index.(51.2%)	196
abstract_inverted_index.(N=85).	101
abstract_inverted_index.January	85
abstract_inverted_index.Medical	78
abstract_inverted_index.causing	129
abstract_inverted_index.compare	43
abstract_inverted_index.current	39
abstract_inverted_index.defined	145
abstract_inverted_index.gender,	107
abstract_inverted_index.groups.	116
abstract_inverted_index.groups:	92
abstract_inverted_index.medical	158
abstract_inverted_index.optimal	25
abstract_inverted_index.organs,	126
abstract_inverted_index.outside	6
abstract_inverted_index.overall	170
abstract_inverted_index.present	243
abstract_inverted_index.purpose	36
abstract_inverted_index.reduced	256
abstract_inverted_index.version	161
abstract_inverted_index.(51.8%).	228
abstract_inverted_index.(72.9%).	240
abstract_inverted_index.(84.7%),	235
abstract_inverted_index.Methods:	58
abstract_inverted_index.Pakistan	75
abstract_inverted_index.Patients	87
abstract_inverted_index.Results:	168
abstract_inverted_index.Tertiary	54
abstract_inverted_index.Warfarin	46, 237, 253
abstract_inverted_index.arteries	9
abstract_inverted_index.bleeding	118, 123, 128, 143
abstract_inverted_index.bruising	155
abstract_inverted_index.clinical	109
abstract_inverted_index.critical	125
abstract_inverted_index.efficacy	112
abstract_inverted_index.females.	197
abstract_inverted_index.follows:	208
abstract_inverted_index.included	119
abstract_inverted_index.observed	245
abstract_inverted_index.patients	69, 202
abstract_inverted_index.recorded	113
abstract_inverted_index.referred	17
abstract_inverted_index.remained	32
abstract_inverted_index.treating	48
abstract_inverted_index.(Group-R)	230
abstract_inverted_index.Hospital,	56
abstract_inverted_index.Institute	76
abstract_inverted_index.Medicine,	74
abstract_inverted_index.Sciences,	79
abstract_inverted_index.analysis.	167
abstract_inverted_index.bleeding,	122, 148, 261
abstract_inverted_index.bleeding.	264
abstract_inverted_index.efficacy,	233
abstract_inverted_index.epistaxis	153
abstract_inverted_index.extremity	12
abstract_inverted_index.including	149
abstract_inverted_index.outcomes,	110
abstract_inverted_index.patients,	188
abstract_inverted_index.preferred	251
abstract_inverted_index.pulmonary	8
abstract_inverted_index.requiring	136, 157
abstract_inverted_index.treatment	27, 247
abstract_inverted_index.(Group-W),	238
abstract_inverted_index.(Warfarin)	100
abstract_inverted_index.Department	72
abstract_inverted_index.Islamabad,	80
abstract_inverted_index.Islamabad.	57
abstract_inverted_index.Objective:	0
abstract_inverted_index.Therefore,	34
abstract_inverted_index.controlled	61
abstract_inverted_index.debatable.	33
abstract_inverted_index.occurrence	2
abstract_inverted_index.randomised	60
abstract_inverted_index.thrombosis	22, 31, 67
abstract_inverted_index.Conclusion:	241
abstract_inverted_index.Demographic	102
abstract_inverted_index.Rivaroxaban	44, 229, 249
abstract_inverted_index.categorised	89
abstract_inverted_index.haemoglobin	131
abstract_inverted_index.statistical	166
abstract_inverted_index.46.45±18.01	182
abstract_inverted_index.47.78±17.91	179
abstract_inverted_index.conventional	13
abstract_inverted_index.distribution	200
abstract_inverted_index.investigated	63
abstract_inverted_index.transfusion.	141
abstract_inverted_index.(Rivaroxaban)	95
abstract_inverted_index.intervention.	159
abstract_inverted_index.respectively.	184
abstract_inverted_index.comorbidities,	108
abstract_inverted_index.anticoagulation	26
abstract_inverted_index.thromboembolism	5, 51
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	5
citation_normalized_percentile